Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand
Journal of Associated Medical Sciences · 23.04.2026 · 59 (2) · 421-427
DOI: 10.66285/jams.2026.071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Associated Medical Sciences, online erschienen am 23.04.2026. Verfasst von Jakkrit Khamphakul und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a prominent healthcare-associated pathogen with worldwide implications for public health. Distinguishing between carbapenemase-producing and noncarbapenemase-producing strains over an extended hospitalization period is vital in assessing the risk of treatment failure in infected patients.
Objectives
To study the prevalence of carbapenemase genes and to evaluate the efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase production among CRPA isolated from Thailand. Materials and methods: A total of 164 CRPA isolates were phenotypically tested for carbapenemase production by the mCIM comparing with genotypic detection of carbapenemase genes using the direct flow chip kits and conventional PCR. In addition, carbapenemase genes were identified by sequencing.
Results
The carbapenemase genes, including blaIMP, blaVIM, blaNDM, blaGES, and blaSIM, were found in 83 (50.61%) isolates. The blaIMP showed to be the most prevalent gene, followed by blaVIM and blaNDM, respectively. Of these isolates, 68/83 (82%) of carbapenemase gene-positive isolates were positive by the mCIM assay. The 15 mCIM-negative isolates, six (40%) carried blaVIM-2 gene, while five (33%) isolates contained blaGES-5. Moreover, blaIMP was detected in 3 isolates (20%) and one isolate (7%) of a combination between blaVIM and blaIMP genes. Furthermore, we noted that isolates carrying blaVIM-2 were the most common among the mCIM-negative carbapenemase-producing P. aeruginosa (CPPA), followed by blaGES-5.
Conclusion
This study represents a critical report on using mCIM to detect CPPA. It highlights that relying solely on mCIM may not be sufficient for the comprehensive detection of CPPA. Further approaches are needed to enhance the accuracy of detection in this context.
Zitieren
APA
Khamphakul, J., Jumroon, N., Chaihongsa, N., & Santanirand, P. (2026). Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand. Journal of Associated Medical Sciences, 59(2), 421-427. https://doi.org/10.66285/jams.2026.071
Vancouver
Khamphakul J, Jumroon N, Chaihongsa N, Santanirand P. Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand. Journal of Associated Medical Sciences. 2026;59(2):421-427. doi:10.66285/jams.2026.071
BibTeX
@article{Khamphakul2026,
author = {Khamphakul, Jakkrit and Jumroon, Noppadon and Chaihongsa, Narong and Santanirand, Pitak},
title = {Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand},
journal = {Journal of Associated Medical Sciences},
year = {2026},
volume = {59},
number = {2},
pages = {421--427},
doi = {10.66285/jams.2026.071}
}
EUVIMED